LimeWire vs Mira — how do they compare? LimeWire trades at Rp234.59 (market cap Rp119,81M, Rp16,31M 24h volume), while Mira trades at Rp700.02 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Mira is the larger of the two by market cap, and LimeWire's circulating supply is 510,6M / 633M LMWR (81%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold LimeWire for 13 Days and Mira for 22 Days on average.
| LMWR | MIRA | |
|---|---|---|
Market Cap | Rp119,81M | Rp226,43M |
Volume (24h) | Rp16,31M | Rp101,47M |
Circulating Supply | 510,6M / 633M LMWR (81%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 13 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
LimeWire (LMWR) is trading at Rp234.29 with a market cap of Rp119.94 million, showing a bullish technical signal supported by moving averages. The token is near the pivot point of Rp232, with immediate resistance at Rp238. Current indicators suggest strong trend momentum with ADX readings above 70, while RSI levels remain neutral. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook is cautiously optimistic due to bullish technicals, but limited by neutral oscillators and thin liquidity. Key opportunities include breakout potential above Rp238, while major risks involve low market cap volatility and absence of recent fundamental catalysts. Investors should monitor volume for confirmation of trend strength.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
LimeWire is an AI-powered content platform that revives the iconic peer-to-peer brand from the 2000s. Relaunched in 2022, it reshapes how people share, create, and collaborate with the power of AI. At the center of its ecosystem is the LimeWire Token (LMWR), which functions as a payment and reward method and also powers Blocknode, LimeWire’s decentralized GPU infrastructure (DePIN) marketplace.
Read more on LMWR →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →